(Press-News.org) Contact information: Cristy Lytal
lytal@med.usc.edu
University of Southern California - Health Sciences
USC study reveals a protein that keeps people -- and their skeletons -- organized
Most people think that their planners or their iPhones keep them organized, when proteins such as liver kinase b1 (Lkb1) actually have a lot more to do with it. New research from postdoctoral fellow Lick Lai in the lab of USC scientist Andy McMahon published in Proceedings of the National Academy of Sciences (PNAS) sheds light on how this important protein keeps people organized on a basic level by promoting orderly skeletal growth and preventing skeletal tumors.
In a developing embryo, many bones form based on cartilage templates. The study found that to form these templates, Lkb1 protein controls the progression of immature, dividing cartilage cells into larger, mature and fully differentiated cartilage cells. Without Lkb1, the population of immature cartilage cells disproportionately increases, leading to skeletal tumors.
The way that Lkb1 controls the differentiation of cartilage cells is by suppressing what's known as the "mammalian target of rapamycin (mTOR) pathway" — a very important complex of molecules that coordinates growth in response to available nutrients and other factors. Problems with the mTOR pathway have been implicated in a host of human diseases, including diabetes, obesity, depression and many cancers.
The influence of abnormal Lkb1 isn't restricted to the skeleton, however. Mutant forms of Lkb1 are frequently present in patients with lung, cervical, breast, intestinal, testicular, pancreatic and skin cancers, and in patients with the Peutz–Jeghers syndrome, characterized by benign polyps in the gastrointestinal tract.
"By understanding Lkb1 and the mechanisms that control normal skeletal development, we also learn how we might prevent this development from going awry in cancers and other disorders," said McMahon, who directs the USC Stem Cell initiative and the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC.
INFORMATION:
Co-authors Brendan N. Lilley and Joshua R. Sanes from Harvard University also contributed to the paper.
National Institutes of Health/ National Institute of Diabetes and Digestive and Kidney Diseases Grant P01 DK056246 provided funding for the work in the McMahon lab, and Dr. Lai is a recipient of an Arthritis Foundation Postdoctoral fellowship.
USC study reveals a protein that keeps people -- and their skeletons -- organized
2013-11-14
ELSE PRESS RELEASES FROM THIS DATE:
Novel microbicide gel for vagina and rectum shows potential for HIV prevention
2013-11-14
Novel microbicide gel for vagina and rectum shows potential for HIV prevention
Research to be presented at world's largest pharmaceutical sciences meeting
Arlington, Va. — Researchers developed a first-of-its-kind microbicide gel formulation that ...
Topical treatment for psoriasis targets deeper layers of the skin, improves healing
2013-11-14
Topical treatment for psoriasis targets deeper layers of the skin, improves healing
Groundbreaking research to be featured at 2013 AAPS Annual Meeting and Exposition
Arlington, Va. — A novel combination anti-psoriasis therapy has potential for ...
Toxin produced by bacteria could serve as a model for next-generation antibiotics
2013-11-14
Toxin produced by bacteria could serve as a model for next-generation antibiotics
The recent rise in antibiotic-resistant bacteria is a serious public health threat, and there is a need for new therapeutic strategies to combat these infections. A study published by Cell ...
Nicotine withdrawal traced to very specific group of brain cells
2013-11-14
Nicotine withdrawal traced to very specific group of brain cells
Nicotine withdrawal might take over your body, but it doesn't take over your brain. The symptoms of nicotine withdrawal are driven by a very specific group of neurons within a very specific brain region, according ...
Anthrax toxin can lurk for days in cells as a lingering threat
2013-11-14
Anthrax toxin can lurk for days in cells as a lingering threat
The deadly toxin produced by anthrax bacteria can hide out in human cells for days, invisible both to our immune systems and to the cellular machinery responsible for destroying proteins. The findings reported ...
New research reveals dengue fever mystery in 2 US cities both exposed to risk
2013-11-14
PUBLIC RELEASE DATE: 14-Nov-2013
[
| E-mail
]
var addthis_pub="eurekalert"; var addthis_options = "favorites, delicious, digg, facebook, twitter, google, newsvine, reddit, slashdot, stumbleupon, buzz, more"
Share
Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Bridget DeSimone
bdesimone@burnesscommunications.com
301.280.5735
American Society of Tropical Medicine and Hygiene
New research reveals dengue fever mystery in 2 US cities both exposed to risk
ASTMH Annual Meeting showcases new findings on dengue and risks of future ...
A CNIO team discovers that senescence also plays a role in embryo development
2013-11-14
A CNIO team discovers that senescence also plays a role in embryo development
Researchers postulate that senescence appeared during evolution as a developmental mechanism: as the embryo grows and its different tissues change, senescence switches ...
New malaria vaccines roadmap targets next generation products by 2030
2013-11-14
New malaria vaccines roadmap targets next generation products by 2030
Partners agree on approach for developing vaccines capable of reducing malaria cases by 75 percent, and to enable malaria elimination
WASHINGTON, DC - 14 November 2013 – The world should aim to have vaccines which ...
Anthrax bacteria play hide and seek
2013-11-14
Anthrax bacteria play hide and seek
An EPFL team discovers that, using exosomes, the lethal factor of the anthrax bacterium can travel undetected through the body for days
The bacterium responsible for anthrax develops a strategy reminiscent ...
A*STAR scientists bring to light mechanism of drug for infections
2013-11-14
A*STAR scientists bring to light mechanism of drug for infections
New knowledge of drug mechanism paves road to new treatment approaches for patients suffering from frequent bacterial infections
1. Scientists at A*STAR's ...